Author = Nigel P Murray
The Possible Role of Matrix Metalloprotienase-2 in the Relapse in Patients with Stage II Colon Cancer Treated by Curative Surgery

Volume 24, Issue 10, October 2023, Pages 3373-3379

Nigel P Murray; Ricardo Villalon; Socrates Aedo; Dan Hartmann; Maria P Rodriguez

Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells

Volume 20, Issue 11, November 2019, Pages 3385-3389

Nigel P Murray; Cynthia Fuentealba; Eduardo Reyes; Marco Antonio Lopez; Anibal Salazar; Simona Minzer; Lorena Munoz; Shenda Orrego; Eghon Guzman; Lucas Arzeno

10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical Prostatectomy

Volume 19, Issue 6, June 2018, Pages 1577-1583

Nigel P Murray; Socrates Aedo; Cynthia Fuentealba; Eduardo Reyes

Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome

Volume 19, Issue 1, January 2018, Pages 229-236

Nigel P Murray; Socrates Aedo; Cynthia Fuentealba; Eduardo Reyes; Anibal Salazar

Head to Head Comparison of the Chun Nomogram, Percentage Free PSA and Primary Circulating Prostate Cells to Predict the Presence of Prostate Cancer at Repeat Biopsy

Volume 17, Issue 6, July 2016, Pages 2941-2946

Nigel P Murray; Nigel Murray; Eduardo Reyes; Nelson Orellana; Cynthia Fuentealba; Omar Jacob